1-4 of 4
Shelly Burgett
Close
Sort by
Journal Articles

The Use of Chronic Transfusions in Sickle Cell Disease for Non-Stroke Related Indications

Lindsay Mize, RN, MSN, CPNP, Shelly Burgett, RN, MSN, FNP, Julia Xu, MD, Jennifer Rothman, MD, Nirmish Shah, MD
Journal: Blood
Blood (2014) 124 (21): 4934.
https://doi.org/10.1182/blood.V124.21.4934.4934
Published: 2014
Journal Articles

Hydroxyurea Reduces Conversion From Conditional to Abnormal TCD Velocities In Children with Sickle Cell Anemia (SCA)

Jennifer Rothman, MD, Shelly Burgett, MSN, Russell E. Ware, MD, PhD, Courtney Thornburg, MD, MS
Journal: Blood
Blood (2010) 116 (21): 270.
https://doi.org/10.1182/blood.V116.21.270.270
Published: 2010
Journal Articles

Efficacy of Hydroxyurea To Prevent Organ Damage in Young Children with Sickle Cell Anemia.

Courtney D. Thornburg, MD, MS, Natalia Dixon, MD, Shelly Burgett, FNP, Nicole A. Mortier, MHS, PA-C, Sherri A. Zimmerman, MD, Melanie J. Bonner, PhD, Agustin Calatroni, MA MS, Russell E. Ware, MD PhD
Journal: Blood
Blood (2007) 110 (11): 3386.
https://doi.org/10.1182/blood.V110.11.3386.3386
Published: 2007
Journal Articles

Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia

Sherri A. Zimmerman, William H. Schultz, Shelly Burgett, Nicole A. Mortier, Russell E. Ware
Journal: Blood
Blood (2007) 110 (3): 1043–1047.
https://doi.org/10.1182/blood-2006-11-057893
Published: 2007